PRESS RELEASE published on 04/11/2023 at 11:01, 1 year 7 months ago Original-Research: Energiekontor AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 03/31/2023 at 11:20, 1 year 7 months ago Energiekontor impresses with strong increase in earnings in the 2022 financial year - Record result of the previous year exceeded
PRESS RELEASE published on 02/08/2023 at 07:05, 1 year 9 months ago Energiekontor AG: Successful cooperation continued - Energiekontor sells wind farm in North Rhine-Westphalia with a generation capacity of 11.2 MW after a repowering to ENCAVIS
PRESS RELEASE published on 01/16/2023 at 08:20, 1 year 10 months ago Energiekontor AG: Energiekontor sells solar park with a generation capacity of some 19 MWp in Brandenburg to CEE Group
Published on 11/22/2024 at 23:55, 9 hours 27 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 52 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 17 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 52 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 29 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 27 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 22 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
